Viewing Study NCT00887068

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-01-26 @ 11:23 PM
Study NCT ID: NCT00887068
Status: COMPLETED
Last Update Posted: 2020-01-14
First Post: 2009-04-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None AML View
None MDS View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Acute myelogenous leukemia View
None AML View
None Myelodysplastic syndrome View
None MDS View
None Remission View
None Allogeneic stem cell transplant View
None Allotx View
None Azacitidine View
None 5-Azacitidine View
None 5-aza View
None Vidaza View
None 5-AZC View
None AZA-CR View
None Ladakamycin View
None NSC-102816 View